Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check4 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov software/content revision label (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the study record content.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0; this appears to be a metadata change with no impact on study details or user experience.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0 and related topics 'Multiple Myeloma' and 'MedlinePlus Genetics' were added.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the related 'MedlinePlus Genetics' topics from the study page.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 was added and the prior v3.4.1 note along with a government funding status notice were removed.SummaryDifference0.3%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.